Scott Akamine

General Counsel, Cerevel Therapeutics Holdings, Inc.

Companies

Kailera Therapeutics, Inc.General counsel Apr 16, 2026 to now¹
Cerevel Therapeutics Holdings, Inc.General counsel May 28, 2021 to Aug 5, 2024²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 1, 2024Returned to company 7,527 shares of Cerevel Therapeutics Holdings, Inc.³
Dec 20, 2023Sold 7,072 shares at $41.42 of Cerevel Therapeutics Holdings, Inc.⁴
Dec 19, 2023Exercised options 13,796 shares of Cerevel Therapeutics Holdings, Inc.⁴
Dec 7, 2023Sold 10,000 shares at $41.37 of Cerevel Therapeutics Holdings, Inc.⁵
Dec 7, 2023Exercised options 10,000 shares at $13.17 of Cerevel Therapeutics Holdings, Inc.⁵
Dec 5, 2023Sold 7,500 shares at $35.00 of Cerevel Therapeutics Holdings, Inc.⁵
Dec 5, 2023Exercised options 7,500 shares at $13.17 of Cerevel Therapeutics Holdings, Inc.⁵
Aug 8, 2022Sold 10,000 shares at $40.00 of Cerevel Therapeutics Holdings, Inc.⁶
Aug 8, 2022Exercised options 10,000 shares at $13.17 of Cerevel Therapeutics Holdings, Inc.⁶

The numbers on this page point here. Each one links to the record it came from.